RSV Prevention, Part V: Where Are We Now?
Summary
In the fifth installment of our Respiratory Syncytial Virus (RSV) prevention series, Avalere experts discuss updates to the RSV prevention landscape, including newly approved products and recent Advisory Committee on Immunization Practices (ACIP) meeting discussions.
2025: Opportunity Through Uncertainty
Sign Up for Our 2025 Healthcare Industry Outlook Webinar
Register Now
January 23, 11 AM ET
Learn MoreServices
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.